Lawrence Friedhoff

5.0k citations
55 papers · 3.9k · 3 hit papers · h-index 18

Impact in

Papers in

    • Cholinesterase and Neurodegenerative Diseases 9
    • Antibiotics Pharmacokinetics and Efficacy 7
    • Treatment of Major Depression 7

Lawrence Friedhoff

55 papers receiving 3.6k citations

Lawrence Friedhoff's Hit Papers

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study 2015 · 583 citations
5830+10+20Years since publication4008001.2k

Peers

Lawrence Friedhoff
Comparison fields: 5 of 133
  • Psychiatry and Mental health 1.2k
  • Pharmacology 1.1k
  • Neurology 335
  • Geriatrics and Gerontology 134
  • Physiology 892
Replace Samantha Rogers with:
Samantha Rogers United Kingdom
Shelia Jin United States
Christopher Ernesto United States
Hans Jörg Möbius Germany
Ara S. Khachaturian United States
Sean Lilienfeld United States
Albrecht Stöffler Germany
Roger Lane United States
Kimberly Schafer United States
G K Wilcock United Kingdom
Lawrence Friedhoff relative to Samantha Rogers United Kingdom Samantha Rogers's profile →
Citations per field
00.5×3.8×
Samantha Rogers · 1×
Citations per year

Countries citing papers authored by Lawrence Friedhoff

Since Specialization
Citations

This map shows the geographic impact of Lawrence Friedhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Friedhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Friedhoff more than expected).

Fields of papers citing papers by Lawrence Friedhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Friedhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Friedhoff. The network helps show where Lawrence Friedhoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Lawrence Friedhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence Friedhoff Line = papers co-authored together Lawrence Friedhoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Hit paper breakdown →
19981271
2
The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
Hit paper breakdown →
1996609
3
DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study
Hit paper breakdown →
2015583
4 1999480
5 1998222
6 200186
7 200070
8 200161
9 201155
10 201447
11 201646
12 200233
13 198124
14 200223
15 198519
16 200419
17 199517
18
Serotonin induced platelet aggregation in systemic sclerosis.
198517
19 198416
20 198616

About Lawrence Friedhoff

Lawrence Friedhoff is a scholar working on Pharmacology, Molecular Biology, Psychiatry and Mental health, Oncology and Pediatrics, Perinatology and Child Health, having authored 55 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Treatment of Major Depression (7 papers), Alzheimer's disease research and treatments (5 papers), Schizophrenia research and treatment (4 papers), Computational Drug Discovery Methods (4 papers), Dementia and Cognitive Impairment Research (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.2k citations), Pharmacology (1.1k citations), Neurology (335 citations), Geriatrics and Gerontology (134 citations) and Physiology (892 citations). Lawrence Friedhoff has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Samantha Rogers, Sharon L. Rogers, Martin R. Farlow, Richard C. Mohs, Rachelle S. Doody, Geetha Ramaswamy, Ilise Lombardo, Stephen C. Piscitelli, Martin N. Rossor and Alistair Burns. Their work appears in journals such as European Neuropsychopharmacology, Alzheimer s & Dementia, Antimicrobial Agents and Chemotherapy, Critical Care Medicine and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact